Would the Per Se Illegal Treatment of Reverse Payment Settlements Inhibit Generic Drug Investment?
Journal of Competition Law and Economics - United Kingdom
doi 10.1093/joclec/nhs021
Full Text
Open PDFAbstract
Available in full text
Date
August 7, 2012
Authors
Publisher
Oxford University Press (OUP)